Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HK.3.11EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.3.11EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.3.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.3.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JC.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JC.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JC.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
JC.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JC.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JC.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JC.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JC.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.564EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.564EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.564ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.564ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.564EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.564EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.564ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.564ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.461EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.461EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.461ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.461ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.461EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.461EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.461ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.461ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Q.1 (Alpha)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
Q.1 (Alpha)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Q.1 (Alpha)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
Q.1 (Alpha)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Q.1 (Alpha)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
Q.1 (Alpha)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Q.1 (Alpha)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Q.1 (Alpha)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.46 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.46 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.46 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.46 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.46 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.46 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.46 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.46 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.99 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.99 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.99 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.99 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.99 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.99 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used